Nicolas Fraunhoffer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Nicolas Fraunhoffer
May 14, 2025, 12:34 | Science
Nelson Dusetti: The Use of Pancreas-View GEM to Personalize Adjuvant Chemotherapy and Improve Outcomes in PDAC
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre…
May 5, 2025, 14:24 | Insight
Nelson Dusetti: Advancing Pancreatic Cancer Research with ARARD Foundation
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Mar 25, 2025, 11:05 | Blog
Nelson Dusetti: PANCprofiler - A step forward in personalizing pancreatic cancer treatment
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Dec 1, 2024, 21:26 | Blog
Nelson Dusetti: Nicolas Fraunhoffer and Brice Chanez have been awarded funding from Canceropôle Provence-Alpes-Côte d'Azur
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Sep 12, 2024, 17:36 | Insight
Nelson Dusetti: A major advancement in transcriptomic signatures for predicting treatment sensitivity in pancreatic cancer
Nelson Dusetti shared on LinkedIn: "We are thrilled to announce a major advancement in transcriptomic…
Jun 22, 2024, 14:12 | Insight
New Paper Alert! Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures
Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures Authors: Nicolas Fraunhoffer,…
All: 6 Posts: 1 - 100
Special Coverage